Original Literature | Model OverView |
---|---|
Publication
Title
Endotoxin signal transduction in macrophages.
Affiliation
Centre for Molecular and Cellular Biology, University of Queensland, Brisbane,Australia.
Abstract
Through its action on macrophages, bacterial lipopolysaccharide (LPS) orendotoxin can trigger responses that are protective or injurious to the host.This review examines the effects of LPS on macrophages by following events fromthe cell surface to the nucleus. The involvement of protein tyrosine kinases,mitogen-activated protein kinases, protein kinase C, G proteins, protein kinaseA, ceramide-activated protein kinase, and microtubules in this process arereviewed. At the nuclear level, rel, C/EBP, Ets, Egr, fos, and jun familymembers have been implicated in activation of LPS-inducible gene expression.
PMID
8699127
|
Entity
Process
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
Raf-1
--
MO000000015
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000015 |
--
PKC
--
MO000000104
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m92
10
infinite
0
TRANSPATH | MO000000104 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
STAT1
--
MO000013119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1357
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
IL-1beta
--
MO000016597
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1591
10
infinite
0
TRANSPATH | MO000016597 |
--
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
STAT1{p}
--
MO000019704
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4238
10
infinite
0
TRANSPATH | MO000019704 |
--
LPS:LBP:CD14
--
MO000021929
cso30:c:Protein
cso30:i:CC_CellComponent
--
p4 p5 p6 p7 p8 p9 p11 p13 p16 p18 p20 p21 p26 p27 p28 p31 p34 p35 p36 p40 p42 p43 p52 p53 p54 p55 p56 p57 p58 p61 p75
csml-variable:Double
m6255
10
infinite
0
TRANSPATH | MO000021929 |
--
PU.1
--
MO000037579
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m15836
10
infinite
0
InterPro | IPR002341 |
TRANSPATH | MO000037579 |
--
Raf-1{p}
--
MO000038411
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16621
10
infinite
0
TRANSPATH | MO000038411 |
--
NF-kappaB1
--
MO000100032
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m73069
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000100032 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LynA{p}
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
LynB{p}
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
p58HCK
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
p58HCK{p}
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
p64HCK
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
p64HCK{p}
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
c-fgr
--
e17
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
c-fgr{p}
--
e18
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
MAPK
--
e19
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
MAPK{active}
--
e20
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
RSK6
--
e21
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
RSK6{p}
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
CSF1
--
e24
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m25
0
infinite
0
--
CSF1R
--
e25
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m26
0
infinite
0
--
CSF1:CSF1R
--
e26
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m27
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
PKC{active}
--
e30
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
TRANSPATH | MO000000104 |
--
MacMARCKS
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
MacMARCKS{active}
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
LPS:PKC
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
muramyl dipeptide
--
e35
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m37
0
infinite
0
--
muramyl dipeptide:PKC
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
csml-variable:Double
m39
0
infinite
0
--
CAK{active}
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
csml-variable:Double
m42
0
infinite
0
--
PT
--
e41
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
Nitric oxide
--
e42
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m44
0
infinite
0
--
membrane protein
--
e43
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m45
0
infinite
0
--
membrane protein{adp-ribose}
--
e44
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m46
0
infinite
0
--
MAP2
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
LPS:MAP2
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m48
0
infinite
0
--
taxol
--
e47
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
MAP2{p}
--
e48
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m63
0
infinite
0
--
CD11c:CD18
--
e5
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LPS:CD11c:CD18
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
genestein
--
e63
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
MIP-1alpha
--
e64
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m67
0
infinite
0
--
FcgammaR1b
--
e65
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m68
0
infinite
0
--
csml-variable:Double
m69
0
infinite
0
--
PU.1:TFIID
--
e67
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
PKA{active}
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
PKA
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
csml-variable:Double
m73
0
infinite
0
--
csml-variable:Double
m74
0
infinite
0
--
NFkappaB:IkappaB
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
IkappaB
--
e73
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m76
0
infinite
0
--
protein remnants
--
e74
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
IkappaB{p}:NF-kappaB
--
e75
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m78
0
infinite
0
--
NF-kappaB
--
e76
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
csml-variable:Double
m80
0
infinite
0
--
NF-IL6
--
e78
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m81
0
infinite
0
--
NF-IL6{p}
--
e79
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m82
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
NF-kappaB:NF-IL6
--
e80
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m83
0
infinite
0
--
AP-1:NF-IL6
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m84
0
infinite
0
--
IFN-gamma
--
e82
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m85
0
infinite
0
--
IFN-gammaR
--
e83
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m86
0
infinite
0
--
IFNgamma:IFNgammaR
--
e84
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m87
0
infinite
0
--
IFNgamma:IFNgammaR:JAK1
--
e85
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m88
0
infinite
0
--
IFNgamma:IFNgammaR:JAK2
--
e86
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m89
0
infinite
0
--
Stat1{p}:Stat1{p}
--
e87
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m90
0
infinite
0
--
Stat1{p}:Stat1{p}
--
e88
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m91
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
IRF-9
--
e90
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m94
0
infinite
0
--
IRF-9{active}
--
e91
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m95
0
infinite
0
--
csml-variable:Double
m96
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m3985*m155666*0.1
nodelay
--
0
PMID: 8699127 The most characterised interaction is between LPS and LPS binding protein which shares homology with the neutrophil protein bactericidal/permeability-increasing protein.
p10
p10
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c30 : 1
stoichiometry:c29 : 1
m20*m16621*0.1
nodelay
--
0
PMID: 8699127, 7799956 Raf-1 may participate in the activation of MAPK via both ras-dependent and independent mechanisms in macrophages.
p11
p11
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c32 : 1
m22*m21*m6255*0.1
nodelay
--
0
PMID: 8699127, 7650392 One of the substrates of MAP kinase(s) is another kinase, ribosomal S6 kinase (rsk) which also becomes phosphorylated in LPS- or peptidoglycan-stimulated cells.
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c39 : 1
stoichiometry:c38 : 1
m119*m6255*0.1
nodelay
--
0
PMID: 8699127, 8513862 This effect appears to be phospholipase C dependent.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m25*m26*0.1
nodelay
--
0
p15
p15
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c45 : 1
stoichiometry:c44 : 1
m549*m27*0.1
nodelay
--
0
PMID: 8699127, 8247534 CSF-1 was shown to activate the 44- (ERK-1) and 40-kDa (ERK-2) isoforms of MAPK in murine BAC-1.2F5 macrophages.
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c48 : 1
stoichiometry:c47 : 1
m549*m6255*0.1
nodelay
--
0
PMID: 8699127, 7989771 LPS activated both ERK-1 and ERK-2 in BAC-1.2F5 cells and that both CSF-1 and LPS activated raf-1 through similar mechanisms.
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c53 : 1
stoichiometry:c50 : 1
m554*m27*0.1
nodelay
--
0
PMID: 8699127, 8247534 CSF-1 was shown to activate the 44- (ERK-1) and 40-kDa (ERK-2) isoforms of MAPK in murine BAC-1.2F5 macrophages.
p18
p18
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c54 : 1
stoichiometry:c52 : 1
m554*m6255*0.1
nodelay
--
0
PMID: 8699127, 7989771 LPS activated both ERK-1 and ERK-2 in BAC-1.2F5 cells and that both CSF-1 and LPS activated raf-1 through similar mechanisms.
p19
p19
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c57 : 1
stoichiometry:c56 : 1
m19*m27*0.1
nodelay
--
0
PMID: 8699127, 7989771 LPS activated both ERK-1 and ERK-2 in BAC-1.2F5 cells and that both CSF-1 and LPS activated raf-1 through similar mechanisms.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m2828*m6254*0.1
nodelay
--
0
PMID: 8699127, 1698311, 1375269, 7681085 The LBP/LPS complex binds the monocyte/macrophage-specific surface receptor, CD14
p20
p20
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c60 : 1
stoichiometry:c59 : 1
m30*m6255*0.1
nodelay
--
0
PMID: 8699127, 7693711 In 70Z/3 B cells stably expressing human CD14, LPS binding causedthe rapid tyrosine phosphorylation of a 38-kDa protein, p38, which is distinct from ERK-1 and ERK-2.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c63 : 1
stoichiometry:c62 : 1
m92*m6255*0.1
nodelay
--
0
PMID: 8699127, 7519214, 1903655 PKC activation by LPS in human monocytes has been documented and has been implicated in activation to a tumoricidal state and in production of TNF-alpha and IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c64 : 1
m32*0.1
nodelay
--
0
PMID: 8699127, 7519214, 1903655 PKC activation by LPS in human monocytes has been documented and has been implicated in activation to a tumoricidal state and in production of TNF-alpha and IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m32*0.1
nodelay
--
0
PMID: 8699127, 7519214, 1903655 PKC activation by LPS in human monocytes has been documented and has been implicated in activation to a tumoricidal state and in production of TNF-alpha and IL-1beta.
p24
p24
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c111 : 1
stoichiometry:c67 : 1
m93309*m43*0.1
nodelay
--
0
PMID: 8699127, 8423328 It is interesting that under the same conditions PT treatment markedly potentiated TNF-a production in response to LPS.
p25
p25
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c71 : 1
m93364*m32*0.1
nodelay
--
0
PMID: 8699127, 7519214, 1903655 PKC activation by LPS in human monocytes has been documented and has been implicated in activation to a tumoricidal state and in production of TNF-alpha and IL-1beta.
p26
p26
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c74 : 1
m6255*0.1
nodelay
--
0
PMID: 8699127, 2156930 LPS stimulated TNF-alpha expression without PKC activation.
p27
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c78 : 1
stoichiometry:c77 : 1
m64002*m6255*0.1
nodelay
--
0
PMID: 8699127, 2006186, 1516135 Low concentrations of LPS rapidly induce the major alaninerich C kinase substrates MARCKS and MacMARCKS, in macrophages.
p28
p28
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c81 : 1
stoichiometry:c80 : 1
m34*m6255*0.1
nodelay
--
0
PMID: 8699127, 2006186, 1516135 Low concentrations of LPS rapidly induce the major alanine rich Ckinase substrates MARCKS and MacMARCKS, in macrophages.
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m92*m155666*0.1
nodelay
--
0
PMID: 8699127, 3465326, 3474155 LPS (and lipid A) and muramyl dipeptide can bind directly to the phosphatidyl serine site of PKC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c9 : 1
stoichiometry:c8 : 1
m5*m155666*0.1
nodelay
--
0
PMID: 8699127 Apart from CD14, CD11c/CD18, a member of the leukocyte integrin family, also has the capacity to activate cells in response to LPS.
p30
p30
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m92*m37*0.1
nodelay
--
0
PMID: 8699127, 3465326, 3474155 LPS (and lipid A) and muramyl dipeptide can bind directly to the phosphatidyl serine site of PKC.
p31
p31
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c90 : 1
stoichiometry:c89 : 1
m39*m6255*0.1
nodelay
--
0
PMID: 8699127, 8021269 LPS activated CAK in a CD14-dependent manner.
p32
p32
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c93 : 1
stoichiometry:c92 : 1
m19*m40*0.1
nodelay
--
0
PMID: 8699127, 7477354 Recent evidence suggests that Raf-1 may be a direct target of CAK,providing an alternative portal of entry into the MAPK pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c96 : 1
stoichiometry:c95 : 1
m39*m41*0.1
nodelay
--
0
PMID: 8699127, 8396314, 8300638 Ceramide is able to propagate signaling through the activation of a ceramide-activated protein kinase.
p34
p34
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c98 : 1
m6255*0.1
nodelay
--
0
PMID: 8699127, 3095921, 2511200 PT inhibited LPS-induced IL-i production in the promonocytic cell line, U937 and the macrophage-like cell line, P388D1.
p35
p35
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c103 : 1
stoichiometry:c97 : 1
m42*m6255*0.1
nodelay
--
0
PMID: 8699127, 3095921, 2511200 PT inhibited LPS-induced IL-i production in the promonocytic cell line, U937 and the macrophage-like cell line, P388D1.
p36
p36
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c104 : 1
m6255*0.1
nodelay
--
0
PMID: 8699127, 8423328 PT also inhibited nitric oxide production from LPS-stimulated mouse peritoneal macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c109 : 1
stoichiometry:c108 : 1
m45*m43*0.1
nodelay
--
0
PMID: 8699127, 8423328 PT also inhibited nitric oxide production from LPS-stimulated mouse peritoneal macrophages and this correlated with ADP-ribosylation of a 41-kDa membrane protein by PT.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c114 : 1
stoichiometry:c113 : 1
m47*m155666*0.1
nodelay
--
0
PMID: 8699127, 8510674 An interaction between LPS and one such protein, MAP-2 was demonstrated using overlay assays.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c117 : 1
stoichiometry:c116 : 1
m20*m49*0.1
nodelay
--
0
PMID: 8699127, 7901279 Both LPS and taxol were able to activate MAPK, which can phosphorylate MAP-2.
p4
p4
cso30:i:ME_Autophosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c12 : 1
stoichiometry:c11 : 1
m16258*m6255*0.1
nodelay
--
0
PMID: 8699127, 8521300 enhancement of autophosphorylation of both p53 and p56 lyn upon LPS addition to primary murine macrophages.
p40
p40
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c120 : 1
stoichiometry:c119 : 1
m20*m6255*0.1
nodelay
--
0
PMID: 8699127, 7901279 Both LPS and taxol were able to activate MAPK, which can phosphorylate MAP-2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c123 : 1
stoichiometry:c122 : 1
m47*m21*0.1
nodelay
--
0
PMID: 8699127, 7901279 Both LPS and taxol were able to activate MAPK, which can phosphorylate MAP-2.
p42
p42
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c126 : 1
stoichiometry:c125 : 1
m2137*m6255*0.1
nodelay
--
0
PMID: 8699127 Two Ets family members, Ets-2 and Elk-1 were demonstrated to be LPS inducible in macrophages.
p43
p43
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
stoichiometry:c128 : 1
m65*m6255*0.1
nodelay
--
0
PMID: 8699127, 7989771 Treatment with the tyrosine kinase inhibitor, genestein, blocked LPS-induced Elk-1 phosphorylation in BAC-1.2F5 macrophages.
p44
p44
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m15836*0.1
nodelay
--
0
PMID: 8699127, 8355682, 8095266, 8264604, 7964503, 8195721, 8302571, 7799967 The expression of genes encoding pro-IL-1beta, macrophage inflammatory protein (MIP)-la, CD1lb Fc¡ÇyRlb and the CSF-l receptor all appear to be regulated by this protein.
p45
p45
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c133 : 1
m15836*0.1
nodelay
--
0
PMID: 8699127, 8355682, 8095266, 8264604, 7964503, 8195721, 8302571, 7799967 The expression of genes encoding pro-IL-1beta, macrophage inflammatory protein (MIP)-la, CD1lb Fc¡ÇyRlb and the CSF-l receptor all appear to be regulated by this protein.
p46
p46
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c135 : 1
m15836*0.1
nodelay
--
0
PMID: 8699127, 8355682, 8095266, 8264604, 7964503, 8195721, 8302571, 7799967 The expression of genes encoding pro-IL-1beta, macrophage inflammatory protein (MIP)-la, CD1lb Fc¡ÇyRlb and the CSF-l receptor all appear to be regulated by this protein.
p47
p47
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c137 : 1
m15836*0.1
nodelay
--
0
PMID: 8699127, 8355682, 8095266, 8264604, 7964503, 8195721, 8302571, 7799967 The expression of genes encoding pro-IL-1beta, macrophage inflammatory protein (MIP)-la, CD1lb Fc¡ÇyRlb and the CSF-l receptor all appear to be regulated by this protein.
p48
p48
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c68 : 1
stoichiometry:c139 : 1
m15836*0.1
nodelay
--
0
PMID: 8699127, 8355682, 8095266, 8264604, 7964503, 8195721, 8302571, 7799967 The expression of genes encoding pro-IL-1beta, macrophage inflammatory protein (MIP)-la, CD1lb Fc¡ÇyRlb and the CSF-l receptor all appear to be regulated by this protein. PMID: 8699127, 3035291, 2548952, 1338337 LPS down regulates CSF-1 receptor expression and is thus a powerful inhibitor of CSF-1 induced growth.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m69*m15836*0.1
nodelay
--
0
PMID: 8699127, 8434021 This model is supported by the observation that PU.l can interactwith the general transcription factor TFIID.
p5
p5
cso30:i:ME_Autophosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c15 : 1
stoichiometry:c14 : 1
m16259*m6255*0.1
nodelay
--
0
PMID: 8699127, 8521300 enhancement of autophosphorylation of both p53 and p56 lyn upon LPS addition to primary murine macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c144 : 1
m71*0.1
nodelay
--
0
PMID: 8699127, 8392062 An increase in JunB mRNA and protein was observed in response to LPS. PMID: 8699127, 8392062 Activation of JunB in response to LPS was independent of PMA-sensitive PKC but required PKA as determined by experiments with kinase inhibitors and agents that elevate intracellular cAMP levels.
p51
p51
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c152 : 1
stoichiometry:c147 : 1
m95154*m71*0.1
nodelay
--
0
PMID: 8699127, 8392062 An increase in JunB mRNA and protein was observed in response to LPS. PMID: 8699127, 8392062 Activation of JunB in response to LPS was independent of PMA-sensitive PKC but required PKA as determined by experiments with kinase inhibitors and agents that elevate intracellular cAMP levels.
p52
p52
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c149 : 1
m6255*0.1
nodelay
--
0
PMID: 8699127, 8392062, 2477086 LPS increased c-jun mRNA in J774cells and in human monocytes.
p53
p53
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c153 : 1
stoichiometry:c146 : 1
m72*m6255*0.1
nodelay
--
0
PMID: 8699127, 8392062 Activation of JunB in response to LPS was independent of PMA-sensitive PKC but required PKA as determined by experiments with kinase inhibitors and agents that elevate intracellular cAMP levels.
p54
p54
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m6255*0.1
nodelay
--
0
PMID: 8699127, 8217790, 3110291 Expression ofthe other AP-1 subunit, c-fos, was also induced by LPS in murine macrophages.
p55
p55
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c162 : 1
stoichiometry:c164 : 1
stoichiometry:c159 : 1
m6255*0.1
nodelay
--
0
PMID: 8699127, 1401930 LPS treatment of murine peritoneal macrophages resulted in rapid induction of Egr-1 mRNA and protein.The effect of LPS on Egr-1 mRNA was inhibited by chronic PMA treatment and by treatment with the PKC inhibitor, H-7 indicating a probable involvement of PMA sensitive PKC in this LPS response.
p56
p56
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
stoichiometry:c163 : 1
stoichiometry:c156 : 1
m6255*m93569*0.1
nodelay
--
0
PMID: 8699127, 1401930 LPS treatment of murine peritoneal macrophages resulted in rapid induction of Egr-1 mRNA and protein.The effect of LPS on Egr-1 mRNA was inhibited by chronic PMA treatment and by treatment with the PKC inhibitor, H-7 indicating a probable involvement of PMA sensitive PKC in this LPS response.
p57
p57
cso30:i:ME_Processing
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c167 : 1
stoichiometry:c166 : 1
m171*m6255*0.1
nodelay
--
0
PMID: 8699127, 8349609 LPS also appears to increase proteolytic processing of p105 to produce NF-KB1
p58
p58
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c171 : 1
stoichiometry:c173 : 1
stoichiometry:c172 : 1
m75*m6255*0.1
nodelay
--
0
PMID: 8699127, 8505309, 7565683 Treatment of human monocytic THP-1 cells with LPS caused phosphorylation of IKBalpha and more recent studies have demonstrated that phosphorylation of IKBalpha on serines 32 and 36 by LPS is necessary for its subsequent degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
stoichiometry:c170 : 1
m73069*m76*0.1
nodelay
--
0
PMID: 8699127 Induction of nuclear NF-kappaB by growth factors, mitogens, cellular activators, and activators of second messengers appears to be mediated by an inhibitor of NF-KB, IKappaB, which binds NF-KB thus forming an inactive cytoplasmic complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c18 : 1
stoichiometry:c17 : 1
m13*m6255*0.1
nodelay
--
0
PMID: 8699127, 7691802 Other tyrosine kinases activated by LPS may include p58/64?yn and p59c-fgr.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c175 : 1
stoichiometry:c176 : 1
m78*0.1
nodelay
--
0
PMID: 8699127, 8505309, 7565683 Treatment of human monocytic THP-1 cells with LPS caused phosphorylation of IKBalpha and more recent studies have demonstrated that phosphorylation of IKBalpha on serines 32 and 36 by LPS is necessary for its subsequent degradation.
p61
p61
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c177 : 1
m6255*0.1
nodelay
--
0
PMID: 8699127, 1380488 NF-IL6 mRNA was increased in tissue samples in response to LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c181 : 1
stoichiometry:c180 : 1
m81*m71*0.1
nodelay
--
0
PMID: 8699127, 8336793, 8200992 PKA and PKC phosphorylated serine 105 in the NF-IL6 activation domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c184 : 1
stoichiometry:c183 : 1
m81*m32*0.1
nodelay
--
0
PMID: 8699127, 8336793, 8200992 PKA and PKC phosphorylated serine 105 in the NF-IL6 activation domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c185 : 1
stoichiometry:c186 : 1
stoichiometry:c187 : 1
m79*m81*0.1
nodelay
--
0
PMID: 8699127, 1518839, 8234276, 7935377, 7706280 Interactions between NF-1L6 and other proteins including NF-KB and AP-1 have been documented.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c188 : 1
stoichiometry:c189 : 1
stoichiometry:c190 : 1
m219*m81*0.1
nodelay
--
0
PMID: 8699127, 1518839, 8234276, 7935377, 7706280 Interactions between NF-1L6 and other proteins including NF-KB and AP-1 have been documented.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c192 : 1
stoichiometry:c193 : 1
m86*m85*0.1
nodelay
--
0
PMID: 8699127, 8197455, 7566171 The binding of IFN-gamma to its receptor activates members of the JAK family of tyrosine kinases, JAK1 and JAK2, which are associated with the IFN-gamma receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c195 : 1
stoichiometry:c196 : 1
m87*m129*0.1
nodelay
--
0
PMID: 8699127, 8197455, 7566171 The binding of IFN-gamma to its receptor activates members of the JAK family of tyrosine kinases, JAK1 and JAK2, which are associated with the IFN-gamma receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c197 : 1
stoichiometry:c198 : 1
stoichiometry:c199 : 1
m87*m130*0.1
nodelay
--
0
PMID: 8699127, 8197455, 7566171 The binding of IFN-gamma to its receptor activates members of the JAK family of tyrosine kinases, JAK1 and JAK2, which are associated with the IFN-gamma receptor
p69
p69
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c202 : 1
stoichiometry:c201 : 1
m1357*m89*0.1
nodelay
--
0
PMID: 8699127, 7690989, 7510216 Activated JAKs in turn phosphorylate STAT1, a member of the STAT family, on tyrosine 701.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c21 : 1
stoichiometry:c20 : 1
m15*m6255*0.1
nodelay
--
0
PMID: 8699127, 7691802 Other tyrosine kinases activated by LPS may include p58/64?yn and p59c-fgr.
p70
p70
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c205 : 1
stoichiometry:c204 : 1
m1357*m88*0.1
nodelay
--
0
PMID: 8699127, 7690989, 7510216 Activated JAKs in turn phosphorylate STAT1, a member of the STAT family, on tyrosine 701.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c207 : 1
m4238*0.1
nodelay
--
0
PMID: 8699127, 8197455 This phosphorylation event allows STAT proteins to dimerize and translocate to the nucleus where they can activate transcription through recognition of promoter elements designated IFN-gamma activation sites.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c208 : 1
stoichiometry:c209 : 1
m90*0.1
nodelay
--
0
PMID: 8699127, 8197455 This phosphorylation event allows STAT proteins to dimerize and translocate to the nucleus where they can activate transcription through recognition of promoter elements designated IFN-gamma activation sites.
p73
p73
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c212 : 1
stoichiometry:c211 : 1
m970*m87*0.1
nodelay
--
0
PMID: 8699127, 1372386 Several other nuclear factors are induced by IFN-gamma including IRF-1/ISGF2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c215 : 1
stoichiometry:c214 : 1
m94*m87*0.1
nodelay
--
0
PMID: 8699127, 1315834 Several other nuclear factors are induced by IFN-gamma including IRF-1/ISGF2 and ISGF3.
p75
p75
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c217 : 1
stoichiometry:c218 : 1
stoichiometry:c216 : 1
m87*m6255*0.1
nodelay
--
0
PMID: 8699127, 7692452, 7684434, 7541763 Genes such as iNOS, which are synergistically activated by LPS and IFN-gamma, have been analyzed at the transcriptional level.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c220 : 1
stoichiometry:c219 : 1
m96*0.1
nodelay
--
0
PMID: 8699127 DNA added to RAW264 cells acts even when added externally, and can induce a range of LPS-like responses including induction of TNF-alpha.
p77
p77
cso30:i:ME_Translation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c221 : 1
stoichiometry:c223 : 1
stoichiometry:c222 : 1
m93309*m96*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c224 : 1
stoichiometry:c225 : 1
m43*0.1
nodelay
--
0
PMID: 8699127, 8423328 It is interesting that under the same conditions PT treatment markedly potentiated TNF-a production in response to LPS.
p24
p79
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c227 : 1
stoichiometry:c226 : 1
m32*m93309*0.1
nodelay
--
0
PMID: 8699127, 7519214, 1903655 PKC activation by LPS in human monocytes has been documented and has been implicated in activation to a tumoricidal state and in production of TNF-alpha and IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c24 : 1
stoichiometry:c23 : 1
m17*m6255*0.1
nodelay
--
0
PMID: 8699127, 7691802 Other tyrosine kinases activated by LPS may include p58/64?yn and p59c-fgr.
p9
p9
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c27 : 1
stoichiometry:c26 : 1
m19*m6255*0.1
nodelay
--
0
PMID: 8699127 LPS addition to BAC-1.2F5 macrophages led to rapid phosphorylation and activation of Raf-1.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--